ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 304

Burden of Childhood Central Nervous System Vasculitis: Identifying High Risk Factors for Poor Cognitive Outcome

Peter J. Gowdie1, Marinka Twilt1, Pascal N. Tyrrell1, Robyn Westmacott2, Tania Cellucci1, Shehla Sheikh1, Nick Blancette1 and Susanne M. Benseler1, 1Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Psychology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: central nervous system involvement, Cognitive dysfunction, pediatric rheumatology and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Childhood primary angiitis of the CNS (cPACNS) is an increasingly recognized, reversible cause of severe neurological and psychiatric deficit such as stroke, refractory seizures and hallucination in previously healthy children. Aggressive immunosuppression has significantly decreased the mortality, however little is known about the long-term neurocognitive burden of cPACNS. Objectibes: To describe the neuropsychological outcome of children with cPACNS, compare the cognitive burden between distinct disease subtypes and identify risk factors for poor neurocognitive outcome.

Methods:

A single-centre cohort study of children with cPACNS based on Calabrese criteria was performed. Children had to have completed a standard neurocognitive evaluation. Demographic characteristics, disease subtypes, clinical features, laboratory markers, neuroimaging studies, brain biopsy findings and treatment regimens were captured. Neurocognitive function was evaluated with a standardized battery of neuropsychological tests including domains of cognitive, social, emotional and adaptive function. The primary study outcome was the Full Scale IQ (FSIQ). Secondary outcomes included neurological function as defined by the Paediatric Stroke Outcome Measure PSOM, Health-related Quality of Life (PedsQL), disease activity and disease damage (VAS). Analysis: Univariate analysis compared variables between distinct disease subtypes; a multivariate prediction model for adverse cognitive outcome was used

Results:

A total of 104 children were diagnosed with primary CNS vasculitis in the study interval, of whom 63 (61%) completed the neuropsychological assessment. Of these 19 had small vessel CNS vasculitis (SVcPACNS) and 44 angiography-positive CNS vasculitis (APcPACNS). The cohort included 28 girls (16 SVcPACNS, 12 APcPACNS) and 35 boys (3 SVcPACNS, 32 APcPACNS), median age at diagnosis was 8.1 years; SVcPACNS patients were older at diagnosis (9.8 vs. 7.5 years). At diagnosis, SVcPACNS patients present significantly more commonly with seizures(79%, p<0.05) and acute behaviour change (47% p<0.05), while hemiparesis was more frequently seen in APcPACNS (91%,p<0.05). Outcome: Overall, the mean FSIQ was 93 (52-132). The mean FSIQ in SVcPACNS was 82 (54-119) and was significantly lower than in APcPACNS, 97 (52-132) (p<0.05). Abnormal FSIQ scores (<85) were seen in 53% of the SVcPACNS and 27% of APcPACNS patients. Children with SVcPACNS had lower scores than APcPACNS in the subdomains of verbal comprehension, working memory and processing speed (p<0.05). Prediction model: Children with SVcPACNS and with seizures were at the highest risk of cognitive deficits.

Conclusion:

Children with cPACNS carry significant disease burden. The inflammation causes drastically impaired cognitive functioning including comprehension, processing speed and memory deficits. Children with SVcPACNS and in particular those presenting with seizures are at the highest risk for adverse cognitive outcome. Early rehabilitation interventions have to be tailored to this high risk group.


Disclosure:

P. J. Gowdie,
None;

M. Twilt,
None;

P. N. Tyrrell,
None;

R. Westmacott,
None;

T. Cellucci,
None;

S. Sheikh,
None;

N. Blancette,
None;

S. M. Benseler,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/burden-of-childhood-central-nervous-system-vasculitis-identifying-high-risk-factors-for-poor-cognitive-outcome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology